Deutsch English Français

Contact

EP0593539

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP0593539

EP0593539 - IRON CHELATE CULTURE MEDIUM ADDITIVE [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 08.05.1998 Database last updated on 11.09.2024
Most recent event Tooltip	08.05.1998	Application deemed to be withdrawn	published on 24.06.1998 [1998/26]
Applicant(s)	For all designated states NOVO NORDISK A/S Novo Allé 2880 Bagsværd / DK
	[N/P]
Former [1994/17]	For all designated states NOVO NORDISK A/S Novo Allé DK-2880 Bagsvaerd / DK
Inventor(s)	01 / SUHR-JESSEN, Peter, Bernt Mosegaard Park 25 DK-3500 Vaerlöse / DK
	[1994/17]
Representative(s)	(deleted)
	[1995/36]
Former [1994/17]	Thalsoe-Madsen, Kine Birgit, et al c/o Novo Nordisk A/S Novo Allé DK-2880 Bagsvaerd / DK
Application number, filing date	92913614.1	18.06.1992
	[1994/17]
	WO1992DK00190
Priority number, date	EP19910610054	21.06.1991 Original published format: EP 91610054
	[1994/17]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO9300423
	Date:	07.01.1993
	Language:	EN
	[1993/02]
	Type:	A1 Application with search report
	No.:	EP0593539
	Date:	27.04.1994
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 07.01.1993 takes the place of the publication of the European patent application.
	[1994/17]
Search report(s)	International search report - published on:	SE	07.01.1993
Classification	IPC:	C12N5/00	[1994/17]
	CPC:	C12N5/005 (EP); C12N2500/24 (EP)
Designated contracting states	AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LI, LU, NL, SE [1994/17]
Title	German:	ADDITIV FÜR KULTURMEDIUM AUF DER BASIS VON EISENCHELATEN	[1994/17]
	English:	IRON CHELATE CULTURE MEDIUM ADDITIVE	[1994/17]
	French:	ADDITIF POUR MILIEU DE CULTURE A BASE DE CHELATE DE FER	[1994/17]
Entry into regional phase	08.12.1993	National basic fee paid
	08.12.1993	Designation fee(s) paid
	08.12.1993	Examination fee paid
Examination procedure	18.01.1993	Request for preliminary examination filed International Preliminary Examining Authority: DE
	08.12.1993	Examination requested [1994/17]
	02.01.1998	Application deemed to be withdrawn, date of legal effect [1998/26]
	30.01.1998	Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [1998/26]
Fees paid	Renewal fee
	03.05.1994	Renewal fee patent year 03
	30.06.1995	Renewal fee patent year 04
	01.07.1996	Renewal fee patent year 05
	Penalty fee
	Additional fee for renewal fee
	30.06.1997	06 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[A]JP63077801 ;
		[A]JP63141584 ;
		[XY]GB2196348 (CESKOSLOVENSKA AKADEMIE VED);
		[Y]EP0274445 (MEDI CULT AS [NO], et al)
		[Y] - Dialog Information Services, File 351, WPI, Dialog Accession No. 008681836, WPI Accession No. 91-185855/26, LOEFFLER-INST: "Chemical absorption of ammonia in viral replication medium - by adding iron citrate which reacts to form mixed ligand complex, used in prodn. of antigens for vaccines", DD,A,286612, 910131, 9126 (Basic).
		[X] - Dialog Information Services, File 351, WPI, Dialog Accession No. 009027456, WPI Accession No. 92-154816/19, TOSOH CORP: "Complete synthetic medium - contains iron citrate, ethanolamine and linolic acid, oleic acid and/or taurine, does not contain protein, cell growth factor, hormone and steroid"; JP,A,04 091 786, 920325, 9219
		[X] - Tibtech, Vol. 7, September 1989 E. SHACTER: "Serum-free media for bulk culture of hybridoma cells and the preparation of monoclonal antibodies", see page 248 - page 253, see page 249, right column.
		[A] - National Library of Medicine, Database Medline, Accession No. 89124403, SCHNEIDER Y.: "Optimisation of hybridoma cell growth and monoclonal antibody secretion in a chemically defined, serum- and protein-free culture medium", & J Immunol Methods 1989 Jan 6;116(1):65-77.
		[X] - National Library of Medicine, Database Medline, Accession No. 88284722, KOVAR J.: "Growth-stimulating effect of ferric citrate on hybridoma cells: characterization and relation to transferrin function", & Hybridoma 1988 Jun; 7(3):255-63.
		[X] - Dialog Information Services, Database BIOSIS, File 5, Dialog Accession No. 9045773, Biosis Accession No. 93030773, FRANEK F.: "Hybridoma growth and monoclonal antibody production in iron-rich protein-free medium effect of nutrient concentration", & Cytotechnology 7 (1), 1991, 33-38.
		[X] - Dialog Information Services, File 155, Medline, Dialog Accession No. 05755034, Medline Accession No. 86056034, REDDEL RR.: "Cell cycle effects of iron depletion on T-47D human breast cancer cells", Exp Cell Res, Dec 1985, 161 (2) p277-84.
		[X] - Dialog Information Services, File 155, Medline, Dialog Accession No. 06308060, Medline Accession No. 87282060, HERSHKO C. et al.: "Modification of iron uptake and lipid peroxidation by hypoxia, ascorbic acid, and alpha-tocopherol in iron-loaded rat myocardial cell cultures", & J Lab Clin Med Sep 1987 110 (3) p355-61.
		[A] - Dialog Information Services, File 155, Medline, Dialog Accession No. 02890092, Medline Accession No. 76071092, HILL JH et al.: "Iron-induced enhancement of 67Ga uptake in a model human leukocyte culture system", & J Nucl Med Dec 1975, 16 (12) p1183-6.
		[A] - PATENT ABSTRACTS OF JAPAN, Vol. 12, No. 209, C504; & JP,A,63 077 801, publ 1988-01-13 Nippon Zenyaku Kogyo K.K., & JP63077801 A 00000000
		[A] - PATENT ABSTRACTS OF JAPAN, Vol. 12, No. 398, C538; & JP,A,63 141 584, publ 1988-06-14 Chemo Sero Therapeut Res Inst., & JP63141584 A 00000000

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p